EU explores measures to further cut mercury use

Ban on mercury-based PU elastomers and sphygmomanometers in hospitals possible at low cost, study shows

Introducing further EU-level restrictions on the use of mercury in products such as measuring devices would not have major economic impacts on manufacturers or consumers, a consultancy study for the European commission has shown.

The study was presented to a group of stakeholders by the commission in Brussels last week. It shows that a ban on mercury in polyurethane (PU) elastomers and sphygmomanometers (blood pressure monitors) in the healthcare sector would have a "very small impact".

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.